SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group -- Ignore unavailable to you. Want to Upgrade?


To: sjemmeri who wrote (595)4/19/2006 11:10:02 AM
From: keokalani'nui  Respond to of 625
 
Just took another look at CATG. Think I'll wait longer. JnJ/medx progress looks like a real challenge to abt/catg effort; where once I thought abt had clear sailing. The anti-CD22+ program, with the preferred product, is a long way away. Possible mid-term surprise would be the genzyme program, but that would be, well, a surprise. No position.